Millennium Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,000
Closed -$304K 5864
2024
Q1
$304K Buy
+10,000
New +$335K ﹤0.01% 5133
2023
Q1
Sell
-10,000
Closed -$444K 6349
2022
Q4
$444K Buy
+10,000
New +$418K ﹤0.01% 4828
2021
Q4
Sell
-10,000
Closed -$696K 6760
2021
Q3
$696K Buy
+10,000
New +$770K ﹤0.01% 5025

Other funds holding ATRC

Millennium Management's ATRC Position: Q1 2026 in Review

Millennium Management increased its AtriCure (ATRC) stake by 9.8% in Q1 2026, buying an estimated $549K and bringing the position to 179,886 shares worth $5.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2907.

Millennium Management first reported a position in ATRC in Q3 2013 and has held it in 48 quarters since. The position peaked at $68.8M in Q4 2021. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

  • Millennium Management held 179,886 shares of AtriCure worth $5.13M as of Q1 2026.
  • Millennium Management bought 16,091 AtriCure shares in Q1 2026, an estimated $549K.
  • AtriCure made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2907 holding.
  • Millennium Management first reported a position in AtriCure in Q3 2013 and has held it in 48 quarters since.
  • Millennium Management's AtriCure position peaked at $68.8M in Q4 2021.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.